
In Sept 2021 Kora Healthcare acquired Chifam Inc, a Canadian-based speciality pharma company focussed on immunotherapy and immune modulation. The acquisition of Chifam Inc by Kora Healthcare is via its Canadian entity Kora Healthcare Canada Inc.
Kora Healthcare Canada Inc has its regional office based in Oakville, Ontario.
The acquisition of Chifam Inc provides Kora Healthcare with the operational infrastructure and licenses for greater expansion of its pharma portfolio in Canada and North America. Prior to the acquisition, Chifam had been a long-term distributor of a key drug product for Kora Healthcare in Canada. Following the acquisition, all patients and patient stakeholders can and will continue to be able to source Chifam product via existing and well-established channels.
Our Focus

Medicines that treat or manage secondary conditions arising from, relating to and complicated by underlying serious, chronic and long-term diseases.

Medicines and Medical Devices that treat or manage conditions related to sexual and reproductive health in both women and men.

Healthcare products that manage or treat common conditions that can be self-treated or managed with the assistance of healthcare professionals.